Global Lifecycle Management Support Strengthened Portfolio Control for a Biopharma Company.

A biopharma company needed structured lifecycle management support for its pharmaceutical portfolio across various global markets. Freyr delivered comprehensive LCM support aimed at streamlining post-approval processes, ensuring submission continuity, and enhancing regulatory oversight across the entire portfolio.

Client Overview
Icon

Client Overview

The client is a biopharma company managing a pharmaceutical portfolio across global markets. The engagement focused on providing end-to-end lifecycle management support to sustain compliance and portfolio continuity across regions.

Background Icon

Background

As portfolio complexity increased across markets, the client needed external support to manage post-approval activities more cohesively. The need centered on maintaining continuity, efficiently handling lifecycle submissions, and supporting global portfolio governance.

Scope Icon

Services in Scope

End-to-end lifecycle management support for a global pharma portfolio.

Ongoing Regulatory operations to manage post-approval changes and market maintenance activities.

Portfolio support across multiple international markets.

Challenge
Challenge

Challenges

Challenge

Complexity of managing lifecycle activities across multiple markets and products.

Challenge

Need to maintain continuity and consistency in global post-approval Regulatory work.

Challenge

Requirement for a scalable support model to handle portfolio-wide LCM demands.

Challenge

Solution

Freyr provided a centralized LCM support model to coordinate Regulatory maintenance activities across the client’s portfolio. This approach improved visibility, consistency, and operational continuity for post-approval management across global markets.

 

1
Challenge

Assessed the portfolio’s lifecycle management needs across markets and products.

2
Challenge

Established a structured support model for Regulatory maintenance and post-approval submissions.

3
Challenge

Coordinated portfolio-level activities to improve consistency across markets.

4
Challenge

Supported ongoing lifecycle work to sustain compliance and business continuity.

Challenge

Impact

Challenge
  • Improved management of the client’s pharma portfolio across global markets.
Challenge
  • Strengthened continuity of post-approval Regulatory support.
Challenge
  • Created a scalable model for ongoing lifecycle management.

 

This engagement shows how a structured LCM model simplifies post-approval complexity across markets. Freyr’s support helped the client shift from fragmented to coordinated global portfolio management, resulting in better operational control and a more sustainable Regulatory framework.